Previous 10 | Next 10 |
Pacific Ethanol (PEIX), Great Panther Mining (GPL), and MediWound (MDWD) are three small-cap stocks that have high earnings and revenue growth potential. With a potential rotation from tech to small-caps, these stocks are the likeliest to outperform. Growth has been outperforming value q...
The following slide deck was published by MediWound Ltd. in conjunction with this Read more ...
Eastman Kodak Company (NYSE: KODK ) +42% as independent review says no laws were broken. More news on: Eastman Kodak Company, Myomo, Inc., Pacific Ethanol, Inc., Stocks on the move, , Read more ...
MediWound (NASDAQ: MDWD ) and exclusive North America licensee Vericel (NASDAQ: VCEL ) have announced that the FDA has accepted marketing application seeking approval of NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal b...
YAVNE, Israel, Sept. 16, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (the “MediWound”), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the U.S. Food and Drug...
MediWound ( MDWD ) has popped up on my scanner several times over the past couple of years following some potent company press releases and catalysts. Admittedly, I would take a look at the headline and then check the ticker only to see a big move followed by a fade, so I have failed to actual...
YAVNE, Israel, Sept. 03, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (the “Company”), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that Sharon Malka, MediWound&...
MediWound (NASDAQ: MDWD ) and exclusive North America licensee Vericel (NASDAQ: VCEL ) a nnounces acceptance of the first delivery of NexoBrid valued at $16.5M to Biomedical Advanced Research and Development Authority (BARDA). More news on: MediWound Ltd., Vericel Corporation, He...
YAVNE, Israel and CAMBRIDGE, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) and its U.S. commercial partner Vericel Corporation (NASDAQ: VCEL) today announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant...
Mediwound Ltd (MDWD) Q2 2020 Earnings Conference Call August 06, 2020, 08:30 ET Company Participants Jeremy Feffer - LifeSci Advisors Sharon Malka - CEO Boaz Gur-Lavie - CFO Conference Call Participants Kevin DeGeeter - Oppenheimer Swayampakula Ramakanth - H.C. Wainwright...
News, Short Squeeze, Breakout and More Instantly...
Research Published in THE LANCET's eClinicalMedicine EscharEx ® Outperforms Non-Surgical Standard of Care in Debridement and Promotion of Healthy Granulation Tissue YAVNE, Israel, July 29, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in ne...
Funds to be used for clinical development of EscharEx ® to treat diabetic foot ulcers (DFUs) Award advances MediWound’s DFU program and its future revenues four years ahead of original schedule YAVNE, Israel, July 16, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd....
Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd PR Newswire GOTHENBURG, Sweden , July 15, 2024 /PRNewswire/ -- Mölnlycke Health Care, a world-leading MedTech company specialising i...